Literature DB >> 10954003

Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics.

P Harding1, O A Carretero, W H Beierwaltes.   

Abstract

BACKGROUND: Cyclooxygenase-2 (COX-2), the inducible isoform of cyclooxygenase, is found in the macula densa of the renal cortex and is upregulated by dietary sodium restriction. Because of this discrete cortical localization, we hypothesized that COX-2 plays a role in the chronic stimulation of renin via the macula densa pathway.
METHODS: We examined the effect of the selective COX-2 inhibitor NS 398 in male Sprague-Dawley rats.
RESULTS: A low sodium diet (0.02% NaCl) for 14 days elevated plasma-renin activity (PRA) nine-fold, from 6.1 +/- 2.0 to 54.9 +/- 6.5 ng angiotensin I (Ang I)/ml per h (P < 0.0001). Selective COX-2 inhibition with NS 398 had no effect on PRA in animals on normal sodium (5.1 +/- 1.3 ng Ang I/ml per h), but decreased PRA by 41% in sodium-restricted rats, to 33.3 +/- 3.6 ng Ang I/ml per h (P < 0.05). Chronic treatment with NS 398 did not decrease renal renin content (31.8 +/- 1.8 versus 33.5 +/- 2.6 ng Ang I/ mg per h, with NS 398 versus controls), nor did it influence systemic blood pressure or renal haemodynamics. Neither urinary sodium excretion nor prostaglandin (PG)E2 excretion was altered in rats given NS 398. Chronic treatment with the non-selective COX inhibitor indomethacin during sodium restriction over 5 days reduced PRA by 35%, from 29.36 +/- 4.81, to 19.13 +/- 2.88 ng Ang I/ml per h (P < 0.05). Indomethacin had no effect on blood pressure or renal blood flow but reduced urinary PGE2 excretion by 70%.
CONCLUSIONS: One component of the chronic stimulation of PRA by dietary sodium restriction via the macula densa pathway appears to involve the induction of COX-2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954003     DOI: 10.1097/00004872-200018080-00016

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Parathyroid hormone-related protein stimulates plasma renin activity via its anorexic effects on sodium chloride intake.

Authors:  Douglas K Atchison; Elizabeth Westrick; David L Szandzik; Kevin L Gordish; William H Beierwaltes
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

2.  Macula densa sensing and signaling mechanisms of renin release.

Authors:  János Peti-Peterdi; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2010-04-01       Impact factor: 10.121

Review 3.  Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.

Authors:  Gary Noroian; David Clive
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Cyclo-oxygenase-2 inhibition increases blood pressure in rats.

Authors:  Klaus Höcherl; Dierk Endemann; Martin C Kammerl; Horst F Grobecker; Armin Kurtz
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

5.  Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging.

Authors:  Kevin L Gordish; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

6.  Differential regulation of renin and Cox-2 expression in the renal cortex of C57Bl/6 mice.

Authors:  Charlotte Wagner; Helga Vitzthum; Hayo Castrop; Karl Schumacher; Michael Bucher; Sybille Albertin; Thomas M Coffman; William J Arendshorst; Armin Kurtz
Journal:  Pflugers Arch       Date:  2003-09-19       Impact factor: 3.657

7.  Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidney.

Authors:  Raymond C Harris
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

8.  Development of vascular renin expression in the kidney critically depends on the cyclic AMP pathway.

Authors:  Björn Neubauer; Katharina Machura; Min Chen; Lee S Weinstein; Mona Oppermann; Maria Luisa Sequeira-Lopez; R Ariel Gomez; Jürgen Schnermann; Hayo Castrop; Armin Kurtz; Charlotte Wagner
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

Review 9.  Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis.

Authors:  Helmut Schmidt; Barry G Woodcock; Gerd Geisslinger
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

10.  Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and β-adrenergic activity.

Authors:  Douglas K Atchison; Pamela Harding; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.